SPRY2 and endometrial carcinoma: Our findings concerning Spry2 localization were consistent with the results of studies by Hausott et al. [36] and Velasco et al. [25] demonstrating a cytoplasmic, but not nuclear, staining for Spry2 in NIH3T3 fibroblasts and human endometrial carcinoma samples, respectively.